NEPHROPLUS — Nephrocare Health Services Share Price
Last trade - 00:00- IN₹61.64bn
- IN₹61.64bn
- IN₹9.99bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 54.24 | ||
| Price to Sales | 6.17 | ||
| EV to EBITDA | 27.15 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | 26.48% | ||
| Operating Margin | 13.77% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 4,372.95 | 5,661.55 | 7,558.12 | 9,988.45 | n/a | n/a | 31.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +87.42 | +23.74 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nephrocare Health Services Limited, formerly Nephrocare Health Services Pvt Ltd, is an India-based company. The Company is primarily engaged in the business of providing dialysis and sale of related healthcare services and products. The Company offers comprehensive dialysis care through the network of clinics from diagnosis to treatment and wellness programs including hemodialysis, home and mobile dialysis, supported by a pharmacy. It has a network of approximately 490 clinics, with 43 clinics internationally across the Philippines, Uzbekistan and Nepal. Its subsidiaries include Nephrocare Health Services Central Asia FE LLC, Nephrocare Health Services International Pte. Ltd, Nephrocare Health Services Nepal Private Limited, and others.
Directors
- Last Annual
- March 31st, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- December 18th, 2009
- Public Since
- December 17th, 2025
- No. of Shareholders
- 43,406
- No. of Employees
- 2,294
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 100,340,717
- Address
- 5th Floor, D Block,, HYDERABAD, 500081
- Web
- https://nephroplus.com/
- Phone
- +91 4042408039
- Auditors
- B S R & Co. LLP
Latest News for NEPHROPLUS
Upcoming Events for NEPHROPLUS
Q2 2027 Nephrocare Health Services Ltd Earnings Release
Similar to NEPHROPLUS
Aakaar Medical Technologies
National Stock Exchange of India
Aatmaj Healthcare
National Stock Exchange of India
ABH Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
FAQ
As of Today at 04:17 UTC, shares in Nephrocare Health Services are trading at IN₹614.35. This share price information is delayed by 15 minutes.
Shares in Nephrocare Health Services last closed at IN₹614.35 and the price had moved by over the past 365 days. In terms of relative price strength the Nephrocare Health Services share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreNephrocare Health Services does not currently pay a dividend.
Nephrocare Health Services does not currently pay a dividend.
Nephrocare Health Services does not currently pay a dividend.
To buy shares in Nephrocare Health Services you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹614.35, shares in Nephrocare Health Services had a market capitalisation of IN₹61.64bn.
Here are the trading details for Nephrocare Health Services:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: NEPHROPLUS
Based on an overall assessment of its quality, value and momentum Nephrocare Health Services is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nephrocare Health Services. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +9.33%.
As of the last closing price of IN₹614.35, shares in Nephrocare Health Services were trading +0.44% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nephrocare Health Services PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹614.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Nephrocare Health Services' directors